34 results on '"Minami, Takuma"'
Search Results
2. Multimodal Telemonitoring for Weight Reduction in Patients With Sleep Apnea: A Randomized Controlled Trial
- Author
-
Murase, Kimihiko, Minami, Takuma, Hamada, Satoshi, Gozal, David, Takahashi, Naomi, Nakatsuka, Yoshinari, Takeyama, Hirofumi, Tanizawa, Kiminobu, Endo, Daisuke, Akahoshi, Toshiki, Moritsuchi, Yasutaka, Tsuda, Toru, Toyama, Yoshiro, Ohi, Motoharu, Tomita, Yasuhiro, Narui, Koji, Matsuyama, Naho, Ohdaira, Tetsuro, Kasai, Takatoshi, Tsuboi, Tomomasa, Gon, Yasuhiro, Yamashiro, Yoshihiro, Ando, Shinichi, Yoshimine, Hiroyuki, Takata, Yoshifumi, Yoshihisa, Akiomi, Tatsumi, Koichiro, Momomura, Shin-ichi, Kuroda, Tomohiro, Morita, Satoshi, Nakayama, Takeo, Hirai, Toyohiro, and Chin, Kazuo
- Published
- 2022
- Full Text
- View/download PDF
3. Night-time frequency of urination as a manifestation of sleep-disordered breathing: the Nagahama study
- Author
-
Tabara, Yasuharu, Kawaguchi, Takahisa, Setoh, Kazuya, Takahashi, Yoshimitsu, Kosugi, Shinji, Nakayama, Takeo, Matsuda, Fumihiko, Minami, Takuma, Takahashi, Naomi, Takeyama, Hirofumi, Morita, Satoshi, Handa, Tomohiro, Komenami, Naoko, Hamada, Satoshi, Murase, Kimihiko, Matsumoto, Takeshi, Wakamura, Tomoko, Hirai, Toyohiro, and Chin, Kazuo
- Published
- 2021
- Full Text
- View/download PDF
4. Prospective associations of sleep apnea, periodic limb movements, and plasma fibrinogen level
- Author
-
Murase, Kimihiko, Azuma, Masanori, Tachikawa, Ryo, Minami, Takuma, Matsumoto, Takeshi, Hamada, Satoshi, Nakatsuka, Yoshinari, Takahashi, Naomi, Takeyama, Hirofumi, Tanizawa, Kiminobu, Oga, Toru, Handa, Tomohiro, Hirai, Toyohiro, and Chin, Kazuo
- Published
- 2021
- Full Text
- View/download PDF
5. Associations between Sleep-Disordered Breathing and Serum Uric Acid and Their Sex Differences: The Nagahama Study.
- Author
-
Sunadome, Hironobu, Murase, Kimihiko, Tabara, Yasuharu, Matsumoto, Takeshi, Minami, Takuma, Kanai, Osamu, Nagasaki, Tadao, Takahashi, Naomi, Hamada, Satoshi, Tanizawa, Kiminobu, Togawa, Jumpei, Uiji, Sayaka, Wakamura, Tomoko, Komenami, Naoko, Setoh, Kazuya, Kawaguchi, Takahisa, Morita, Satoshi, Takahashi, Yoshimitsu, Nakayama, Takeo, and Hirai, Toyohiro
- Abstract
Sleep-disordered breathing (SDB) is often accompanied by noncommunicable diseases (NCDs), including gout. However, the association between serum uric acid (sUA) levels and NCDs is complicated in patients with SDB. We aimed to clarify this issue utilizing large-scale epidemiological data. This community-based study included 9850 inhabitants. SDB and its severity were assessed by a 3% oxygen desaturation index (3% ODI) corrected for sleep duration using wrist actigraphy. The associations between sUA and moderate to severe SDB (MS-SDB) and sUA and NCDs in patients with MS-SDB were analyzed. A total of 7895 subjects were eligible. In females, the prevalence of MS-SDB increased according to an elevation in sUA levels even after adjusting for confounders, and sUA ≥ 5 mg/dL was the threshold. These were not found in males. There was a positive interaction between sUA ≥ 5 mg/dL and female sex for MS-SDB. In females with MS-SDB, the prevalence of diabetes mellitus (DM) increased according to an elevation in sUA levels, and those with sUA ≥ 5 mg/dL showed a higher prevalence of DM than their counterparts. There is a clear correlation between sUA levels and the severity of SDB, and elevated sUA poses a risk for DM in females with MS-SDB. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. Facial trauma with life-threatening bleeding treated by andexanet alfa administration: A case report
- Author
-
Shirakawa, Yasunori, Jingami, Naoto, Ishiguro, Yoshitaka, Minami, Takuma, Shinozuka, Ken, Yunoki, Tomoyuki, and Ohtsuru, Shigeru
- Published
- 2024
- Full Text
- View/download PDF
7. Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).
- Author
-
Minami, Takuma, Watanabe, Hirotoshi, Kato, Takao, Ikeda, Kaori, Ueno, Kentaro, Matsuyama, Ai, Maeda, Junya, Sakai, Yoji, Harada, Hisako, Kuriyama, Akira, Yamaji, Kyohei, Kitajima, Naoki, Kamei, Jun, Takatani, Yudai, Sato, Yuki, Yamashita, Yugo, Mizota, Toshiyuki, and Ohtsuru, Shigeru
- Subjects
- *
INTENSIVE care units , *DRUG efficacy , *EXPERIMENTAL design , *ANESTHESIA , *TIME , *TERTIARY care , *PATIENTS , *INVESTIGATIONAL drugs , *IMIDAZOLES , *HALOPERIDOL , *RANDOMIZED controlled trials , *TREATMENT effectiveness , *DELIRIUM , *EMERGENCY medical services , *RESEARCH funding , *PATIENT safety , *EVALUATION - Abstract
Background: Delirium is common in critically ill patients. Haloperidol has long been used for the treatment of delirium. Dexmedetomidine has recently been used to treat delirium among intubated critically ill patients. However, the efficacy of dexmedetomidine for delirium in non-intubated critically ill patients remains unknown. We hypothesize that dexmedetomidine is superior to haloperidol for sedation of patients with hyperactive delirium, and would reduce the prevalence of delirium among non-intubated patients after administration. We will conduct a randomized controlled trial to compare dexmedetomidine and haloperidol for the treatment of nocturnal hyperactive delirium in non-intubated patients in high dependency units (HDUs). Methods: This is an open-label, parallel-group, randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for nocturnal hyperactive delirium in non-intubated patients at two HDUs of a tertiary hospital. We will recruit consecutive non-intubated patients who are admitted to the HDU from the emergency room, and allocate them in a 1:1 ratio to the dexmedetomidine or haloperidol group in advance. The allocated investigational drug will be administered only when participants develop hyperactive delirium (Richmond Agitation-Sedation Scale [RASS] score ≥1 and a positive score on the Confusion Assessment Method for the ICU between 19:00 and 6:00 the next day) during the night at an HDU. Dexmedetomidine is administered continuously, while haloperidol is administered intermittently. The primary outcome is the proportion of participants who achieve the targeted sedation level (RASS score of between -3 and 0) 2h after the administration of the investigational drug. Secondary outcomes include the sedation level and prevalence of delirium on the day following the administration of the investigational drugs, and safety. We plan to enroll 100 participants who develop nocturnal hyperactive delirium and receive one of the two investigational drugs. Discussion: This is the first randomized controlled trial to compare the efficacy and safety of dexmedetomidine and haloperidol for sedation of non-intubated critically ill patients with hyperactive delirium in HDUs. The results of this study may confirm whether dexmedetomidine could be another option to sedate patients with hyperactive delirium. Trial registration: Japan Registry of Clinical Trials, jRCT1051220015, registered on 21 April 2022. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. Sleep disordered breathing and haemoglobin A1c levels within or over normal range and ageing or sex differences: the Nagahama study.
- Author
-
Matsumoto, Takeshi, Murase, Kimihiko, Tabara, Yasuharu, Minami, Takuma, Kanai, Osamu, Takeyama, Hirofumi, Sunadome, Hironobu, Nagasaki, Tadao, Takahashi, Naomi, Nakatsuka, Yoshinari, Hamada, Satoshi, Handa, Tomohiro, Tanizawa, Kiminobu, Nakamoto, Isuzu, Wakamura, Tomoko, Komenami, Naoko, Setoh, Kazuya, Kawaguchi, Takahisa, Tsutsumi, Takanobu, and Morita, Satoshi
- Subjects
AGE differences ,SLEEP disorders ,SLEEP apnea syndromes ,SLEEP duration ,PULSE oximeters ,SLEEP interruptions ,AGE - Abstract
Summary: Recently an association between blood glucose dysregulation and sleep disruption was suggested. The association between sleep disordered breathing, most of which is due to obstructive sleep apnea (OSA) in the general population, and diabetic severity, as well as the impact of antidiabetic treatment, remains unclear. This study aimed to investigate these associations as well as age and sex differences. This cross‐sectional study evaluated 7,680 community participants as the main cohort (population‐based cohort). OSA was assessed by the 3% oxygen desaturation index from pulse oximetry, which was corrected for sleep duration obtained by wrist actigraphy. For arguing the limitations for using pulse oximetry, 597 hospitalised patients, who were assessed by the apnea–hypopnea index from attended polysomnography, were also evaluated as the validation cohort (hospital‐based cohort). Moderate‐to‐severe OSA was more prevalent as haemoglobin A1c (HbA1c) levels increased (<5.6%/5.6%–<6.5%/6.5%–<7.5%/≥7.5%, respectively) in both cohorts (p < 0.001), but only in those without antidiabetic treatment. The HbA1c level was an independent factor for moderate‐to‐severe OSA (population‐based cohort, odds ratio [OR] 1.26, 95% confidence interval [CI] 1.10–1.45; hospital‐based cohort, OR 1.69, 95% CI 1.22–2.33, per 1% increase). These associations were more prominent in the middle‐aged (aged <60 years) than in the elderly (aged ≥60 years) and in women than in men in both cohorts. The prevalence of moderate‐to‐severe OSA in patients with antidiabetic treatment in the hospital‐based cohort was ≥75% regardless of HbA1c levels. In conclusion, an association between the prevalence of OSA and HbA1c level even within or over the normal range was found only in patients without antidiabetic treatment and was more prominent in the middle‐aged and in women. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. Rod-like architecture and cross-sectional structure of an amyloid protofilament-like peptide supermolecule in aqueous solution
- Author
-
Minami, Takuma, Matsumoto, Sakiko, Sanada, Yusuke, Waku, Tomonori, Tanaka, Naoki, and Sakurai, Kazuo
- Published
- 2016
- Full Text
- View/download PDF
10. Trauma-Induced Thoracic Stent Graft Migration and Dissecting Aneurysm Rupture
- Author
-
Jingami, Naoto, Yunoki, Tomoyuki, Tazaki, Junichi, Minami, Takuma, Furutake, Tatsuya, Shimoto, Manabu, Sakamoto, Kazuhisa, Kimura, Takeshi, and Ohtsuru, Shigeru
- Published
- 2024
- Full Text
- View/download PDF
11. Microalbuminuria in Patients with Obstructive Sleep Apnea-Chronic Obstructive Pulmonary Disease Overlap Syndrome
- Author
-
Matsumoto, Takeshi, Murase, Kimihiko, Tachikawa, Ryo, Minami, Takuma, Hamada, Satoshi, Tanizawa, Kiminobu, Inouchi, Morito, Handa, Tomohiro, Oga, Toru, Yanagita, Motoko, Mishima, Michiaki, and Chin, Kazuo
- Published
- 2016
- Full Text
- View/download PDF
12. 糖尿病家族歴陽性者の睡眠呼吸障害と糖代謝の関連:ながはまスタディ
- Author
-
Minami, Takuma, 近藤, 尚己, 稲垣, 暢也, and 石見, 拓
- Subjects
heritability ,gene ,environment ,effect modification ,obstructive sleep apnea - Published
- 2021
13. Numerical Description of Breath Sounds in Asthmatic Patients: PS099
- Author
-
Nagasaka, Yukio, Tsuchiya, Michiko, Minami, Takuma, Sakaguchi, Tikara, Kominami, Ryota, Hori, Tetsuo, and Ichinose, Masutarou
- Published
- 2013
14. Sleep disordered breathing and metabolic comorbidities across gender and menopausal status in East Asians; the Nagahama Study
- Author
-
Matsumoto, Takeshi, Murase, Kimihiko, Tabara, Yasuharu, Minami, Takuma, Kanai, Osamu, Takeyama, Hirofumi, Takahashi, Naomi, Hamada, Satoshi, Tanizawa, Kiminobu, Wakamura, Tomoko, Komenami, Naoko, Setoh, Kazuya, Kawaguchi, Takahisa, Tsutsumi, Takanobu, Morita, Satoshi, Takahashi, Yoshimitsu, Nakayama, Takeo, Hirai, Toyohiro, Matsuda, Fumihiko, and Chin, Kazuo
- Subjects
obesity ,hypertension ,diabetes ,Sleep disordered breathing ,sex difference ,mental disorders ,dyslipidemia ,menopause ,cardiovascular diseases ,general population ,metabolic syndrome ,nervous system diseases ,respiratory tract diseases - Abstract
It is well known that the prevalence of sleep disordered breathing (SDB) is increased in patients with obesity or metabolic comorbidities. However, the way in which the prevalence of SDB increases in relation to comorbidities according to the severity of obesity remains unclear. This cross-sectional study evaluated 7713 community participants with nocturnal oximetry ≥2 nights. SDB was assessed by the 3% oxygen desaturation index corrected for sleep duration obtained by wrist actigraphy (Acti-ODI3%). SDB severity was defined by Acti-ODI3%. Obesity was defined as body mass index ≥25 kg·/m−2. The prevalence of SDB was 41.0% (95% CI 39.9–42.1), 46.9% (45.8–48.0), 10.1% (9.5–10.8), and 2.0% (1.7–2.3) in normal, mild, moderate, and severe SDB, respectively, with notable sex differences evident (men >post-menopausal women >pre-menopausal women). Comorbidities such as hypertension, diabetes, and metabolic syndrome were independently associated with the prevalence of moderate-to-severe SDB, and coincidence of any one of these with obesity was associated with a higher probability of moderate-to-severe SDB (OR 8.2, 95% CI 6.6–10.2; 7.8, 5.6–10.9; 6.7, 5.2–8.6, respectively). Dyslipidemia in addition to obesity was not additively associated with the prevalence of moderate to-severe SDB. The number of antihypertensive drugs was associated with SDB (p for trend, 生活習慣病に睡眠時無呼吸症候群がひそむことを解明 --アジア最大資料数のながはまコホートより--. 京都大学プレスリリース. 2020-05-19.
- Published
- 2020
15. Non-invasive ventilation using a novel ventilator and non-vented full-face mask for patients with respiratory failure during the COVID-19 pandemic: Report of three cases
- Author
-
Minami, Takuma, Kai, Shinichi, Tanaka, Tomoharu, Ito, Isao, Kato, Genta, Nagao, Miki, Date, Hiroshi, Hirai, Toyohiro, Ohtsuru, Shigeru, and Chin, Kazuo
- Published
- 2022
- Full Text
- View/download PDF
16. Nocturnal hypercapnia with daytime normocapnia in patients with advanced pulmonary arterial hypertension awaiting lung transplantation.
- Author
-
Nakatsuka, Yoshinari, Chen-Yoshikawa, Toyofumi, Kinoshita, Hideyuki, Aoyama, Akihiro, Kubo, Hiroyasu, Murase, Kimihiko, Hamada, Satoshi, Takeyama, Hirofumi, Minami, Takuma, Takahashi, Naomi, Tanizawa, Kiminobu, Handa, Tomohiro, Hirai, Toyohiro, Date, Hiroshi, and Chin, Kazuo
- Subjects
PULMONARY hypertension ,LUNG transplantation ,HYPERCAPNIA ,CARDIAC output ,PARTIAL pressure - Abstract
Background: Pulmonary arterial hypertension (PAH) is frequently complicated by sleep disordered breathing (SDB), and previous studies have largely focused on hypoxemic SDB. Even though nocturnal hypercapnia was shown to exacerbate pulmonary hypertension, the clinical significance of nocturnal hypercapnia among PAH patients has been scarcely investigated. Method: Seventeen patients with PAH were identified from 246 consecutive patients referred to Kyoto University Hospital for the evaluation of lung transplant registration from January 2010 to December 2017. Included in this study were 13 patients whose nocturnal transcutaneous carbon dioxide partial pressure (PtcCO
2 ) monitoring data were available. Nocturnal hypercapnia was diagnosed according to the guidelines of the American Academy of Sleep Medicine. Associations of nocturnal PtcCO2 measurements with clinical features, the findings of right heart catheterization and pulmonary function parameters were evaluated. Results: Nocturnal hypercapnia was diagnosed in six patients (46.2%), while no patient had daytime hypercapnia. Of note, nocturnal hypercapnia was found for 5 out of 6 patients with idiopathic PAH (83.3%). Mean nocturnal PtcCO2 levels correlated negatively with the percentage of predicted total lung capacity (TLC), and positively with cardiac output and cardiac index. Conclusion: Nocturnal hypercapnia was prevalent among advanced PAH patients who were waiting for lung transplantation, and associated with %TLC. Nocturnal hypercapnia was associated with the increase in cardiac output, which might potentially worsen pulmonary hypertension especially during sleep. Further studies are needed to investigate hemodynamics during sleep and to clarify whether nocturnal hypercapnia can be a therapeutic target for PAH patients. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
17. Adrenal gland size in obstructive sleep apnea: Morphological assessment of hypothalamic pituitary adrenal axis activity.
- Author
-
Minami, Takuma, Tachikawa, Ryo, Matsumoto, Takeshi, Murase, Kimihiko, Tanizawa, Kiminobu, Inouchi, Morito, Handa, Tomohiro, Oga, Toru, Hirai, Toyohiro, and Chin, Kazuo
- Subjects
- *
SLEEP apnea syndromes , *ADRENAL glands , *COMPUTED tomography , *REGRESSION analysis , *MULTIVARIATE analysis - Abstract
Objectives: The association of obstructive sleep apnea (OSA) with hypothalamic pituitary adrenal (HPA) axis activation has not been fully understood from results of previous studies using hormonal assessments. We aimed to investigate the relationship between adrenal size, a potential marker reflecting HPA axis activity, and sleep parameters related to OSA. Methods: We retrospectively reviewed data on 284 consecutive adult patients aged 20 to 80 y who had undergone polysomnography and abdominal computed tomography (CT). OSA was defined as none/mild (apnea-hypopnea index [AHI] <15, n = 75), moderate (AHI 15 to 30, n = 80), and severe OSA (AHI ≥30, n = 129). Widths of adrenal body and limbs were measured by abdominal CT. Results: Adrenal size was greater in participants with severe OSA than in those with none/mild or moderate OSA (adrenal body width: 6.03 mm, none/mild OSA; 6.09 mm, moderate OSA; 6.78 mm, severe OSA; p <0.001; adrenal limb width: 3.75 mm, none/mild OSA; 3.95 mm, moderate OSA; 4.26 mm, severe OSA, p <0.001). Multivariate regression analysis showed that not the 3% oxygen desaturation index and time of SpO2 <90% but a higher arousal index was the only determinant factor for increased adrenal limb width (β = 0.27, p <0.001) after adjusting for other variables that could affect adrenal size. Neither the arousal index nor hypoxic parameters were associated with adrenal body width. Conclusions: Results indicated that adrenal glands may enlarge in response to longstanding sleep fragmentation, suggesting the involvement of OSA in HPA axis augmentation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
18. Optimal Evidence Grading of Simultaneous Use of Hypertonic Saline and Furosemide for Fluid Overload.
- Author
-
Kitajima, Naoki, Yamada, Hiroyuki, Minami, Takuma, and Ohtsuru, Shigeru
- Published
- 2022
- Full Text
- View/download PDF
19. Changes in Habitual Sleep Duration after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.
- Author
-
Ryo Tachikawa, Takuma Minami, Takeshi Matsumoto, Kimihiko Murase, Kiminobu Tanizawa, Morito Inouchi, Toru Oga, Kazuo Chin, Tachikawa, Ryo, Minami, Takuma, Matsumoto, Takeshi, Murase, Kimihiko, Tanizawa, Kiminobu, Inouchi, Morito, Oga, Toru, and Chin, Kazuo
- Subjects
SLEEP apnea syndromes ,SLEEP apnea syndrome treatment ,ANXIETY ,MENTAL depression ,ACTIGRAPHY ,LONGITUDINAL method ,MULTIVARIATE analysis ,PSYCHOLOGICAL tests ,QUALITY of life ,REGRESSION analysis ,SLEEP ,SLEEP stages ,TIME ,POLYSOMNOGRAPHY ,SEVERITY of illness index ,CONTINUOUS positive airway pressure ,PSYCHOLOGY - Abstract
Rationale: Obstructive sleep apnea (OSA) can affect not only sleep quality but also sleep duration. Determining the therapeutic effects of continuous positive airway pressure (CPAP) on habitual sleep profiles may shed light on the impact of OSA on sleep duration.Objectives: To determine whether and how CPAP affects habitual sleep duration in patients with OSA.Methods: Assessments of sleep duration and sleep quality were performed on 57 newly diagnosed study subjects with OSA (46 men; median age, 63 yr; apnea-hypopnea index, >20 h-1) at baseline and 3 months after initiation of CPAP therapy. Measurements included in-laboratory sleep tests (polysomnography), assessments of habitual sleep (actigraphy with sleep diary for 7 d), and questionnaires on subjective symptoms (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, and Hospital Anxiety and Depression Scale).Results: Actigraphic night sleep time did not change after CPAP (from 354.0 ± 64.5 min to 353.0 ± 57.0 min; P = 0.87) in the entire group, despite improvements in sleep efficiency and sleep fragmentation. Changes in habitual night sleep duration varied among the participants; habitual night sleep duration increased by 33 minutes (interquartile range, 14-45 min) in 28 participants (sleep time restorers) and decreased by 23 minutes (interquartile range, -48 to -11 min) in 29 participants (sleep time nonrestorers). Subgroup analyses revealed that sleep time restorers were characterized at baseline as having shorter and more fragmented sleep with frequent daytime napping. Nonrestorers were characterized by frequent use of hypnotic drugs and comorbid insomnia, despite longer habitual sleep duration. Actigraphic sleep fragmentation, sleep efficiency, daytime sleepiness, and the frequency of daytime napping were improved after CPAP only in the sleep time restorers, whereas subjective sleep quality was improved in the nonrestorers. Multivariate linear regression showed that shorter baseline night sleep time, baseline daytime napping, and percentage of sleep time under CPAP were positive predictors of the restoration of actigraphic night sleep time, whereas hypnotic use was a negative predictor.Conclusions: Short-term CPAP did not affect habitual night sleep duration in the group as a whole but induced intraindividual changes in relation to phenotypic features of OSA. Clinical trial registered with www.umin.ac.jp (UMIN000012639). [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
20. Changes in Energy Metabolism after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.
- Author
-
Ryo Tachikawa, Kaori Ikeda, Takuma Minami, Takeshi Matsumoto, Satoshi Hamada, Kimihiko Murase, Kiminobu Tanizawa, Morito Inouchi, Toru Oga, Takashi Akamizu, Michiaki Mishima, Kazuo Chin, Tachikawa, Ryo, Ikeda, Kaori, Minami, Takuma, Matsumoto, Takeshi, Hamada, Satoshi, Murase, Kimihiko, Tanizawa, Kiminobu, and Inouchi, Morito
- Subjects
SLEEP apnea syndrome treatment ,BASAL metabolism ,ENERGY metabolism ,EXERCISE ,HYDROCORTISONE ,INGESTION ,NORADRENALINE ,SLEEP apnea syndromes ,SOMATOMEDIN ,LEPTIN ,POLYSOMNOGRAPHY ,GHRELIN ,CONTINUOUS positive airway pressure - Abstract
Rationale: Disrupted energy homeostasis in obstructive sleep apnea (OSA) may lead to weight gain. Paradoxically, treating OSA with continuous positive airway pressure (CPAP) may also promote weight gain, although the underlying mechanism remains unclear.Objectives: To explore the underlying mechanism by which patients with OSA gain weight after CPAP.Methods: A comprehensive assessment of energy metabolism was performed in 63 newly diagnosed OSA study participants (51 men; 60.8 ± 10.1 yr; apnea-hypopnea index >20 h(-1)) at baseline, CPAP initiation, and at a 3-month follow-up. Measurements included polysomnography, body weight, body composition, basal metabolic rate (BMR), hormones (norepinephrine, cortisol, leptin, ghrelin, insulin-like growth factor-1), dietary intake, eating behavior, and physical activity.Measurements and Main Results: BMR significantly decreased after CPAP (1,584 kcal/d at baseline, 1,561 kcal/d at CPAP initiation, and 1,508 kcal/d at follow-up; P < 0.001), whereas physical activity and total caloric intake did not significantly change. In multivariate regression, baseline apnea-hypopnea index, Δurine norepinephrine, and CPAP adherence were significant predictors of ΔBMR. The weight gainers had higher leptin levels, lower ghrelin levels, and higher eating behavior scores than the non-weight gainers, indicating a positive energy balance and disordered eating behavior among the weight gainers. Among the parameters related to energy metabolism, increased caloric intake was a particularly significant predictor of weight gain.Conclusions: Although a reduction in BMR after CPAP predisposes to a positive energy balance, dietary intake and eating behavior had greater impacts on weight change. These findings highlight the importance of lifestyle modifications combined with CPAP. Clinical trial registered with http://www.umin.ac.jp/english/ (UMIN000012639). [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
21. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
- Author
-
Takeshi Matsumoto, Norio Harada, Masanori Azuma, Yuichi Chihara, Kimihiko Murase, Ryo Tachikawa, Takuma Minami, Satoshi Hamada, Kiminobu Tanizawa, Morito Inouchi, Toru Oga, Michiaki Mishima, Kazuo Chin, Matsumoto, Takeshi, Harada, Norio, Azuma, Masanori, Chihara, Yuichi, Murase, Kimihiko, Tachikawa, Ryo, and Minami, Takuma
- Subjects
FASTING ,INCRETINS ,PROTEOLYTIC enzymes ,REGRESSION analysis ,SLEEP apnea syndromes ,GLUCAGON-like peptide 1 ,GLUCOSE intolerance - Abstract
Rationale: Incretin hormones, namely glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide (GIP), and dipeptidyl peptidase-4 (DPP-4) activity are important factors in glucose metabolism and have not been investigated in patients with obstructive sleep apnea (OSA).Objectives: The objective of this study was to investigate the association between OSA and incretin and DPP-4 activity.Methods: This study included 96 consecutive patients without diabetes who were suspected of having OSA. We investigated the fasting and post-prandial incremental area under the curve (IAUC) of GLP-1, GIP serum levels, and serum DPP-4 activity levels, as well as their association with OSA. Changes in clinical variables were evaluated in the 43 patients who continued continuous positive airway pressure therapy for 3 months.Measurements and Main Results: Apnea-hypopnea index was an independent determining factor for fasting GLP-1 (β = 0.31; P = 0.0019) and IAUC GIP (β = -0.21; P = 0.037) after adjusting for known confounding factors. In those with very severe OSA (apnea-hypopnea index ≥50), the IAUCs for GLP-1 and GIP were significantly decreased, while fasting GLP-1 and fasting GIP were significantly increased. DPP-4 activity had no relation to OSA parameters or severity, while body mass index was significantly higher in those with severe OSA. Although significant changes in incretin secretion were not seen for 3 months after onset of continuous positive airway pressure therapy, the fasting GLP-1 level in the treated patients with severe OSA decreased to the same level as in untreated patients with normal to moderately severe OSA.Conclusions: OSA is associated with elevated serum levels of the incretin hormones GLP-1 (fasting) and GIP (post-prandial) in patients without diabetes. A significant association between body mass index and DPP-4, which is said to exist in healthy persons, was not found in the patients with OSA. Fasting GLP-1 in patients without diabetes with OSA may influence fasting glucose levels. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
22. Microalbuminuria in Patients with Obstructive Sleep Apnea-Chronic Obstructive Pulmonary Disease Overlap Syndrome.
- Author
-
Takeshi Matsumoto, Kimihiko Murase, Ryo Tachikawa, Takuma Minami, Satoshi Hamada, Kiminobu Tanizawa, Morito Inouchi, Tomohiro Handa, Toru Oga, Motoko Yanagita, Michiaki Mishima, Kazuo Chin, Matsumoto, Takeshi, Murase, Kimihiko, Tachikawa, Ryo, Minami, Takuma, Hamada, Satoshi, Tanizawa, Kiminobu, Inouchi, Morito, and Handa, Tomohiro
- Abstract
Rationale: Microalbuminuria is said to reflect systemic vascular damage and endothelial dysfunction and is an established indicator of cardiovascular morbidity and mortality. Patients with obstructive sleep apnea (OSA)-chronic obstructive pulmonary disease (COPD) overlap syndrome have worse survival than those with OSA or COPD alone.Objectives: This study evaluated the association between overlap syndrome and microalbuminuria.Methods: Data on patients in whom OSA was suspected and who underwent polysomnography between January 2010 and December 2012 were reviewed. Microalbuminuria was defined as an albumin-creatinine ratio between 20 and 299 mg/g in men and between 30 and 299 mg/g in women.Measurements and Main Results: Of 740 consecutive patients, 344 were analyzed. Sixty-four were control participants, 248 had OSA only, 4 had COPD only, and 28 had OSA-COPD overlap syndrome. Prevalence of microalbuminuria significantly increased in the order of control, OSA, and overlap syndrome groups (3.1, 12.9, and 32.1%, respectively; P = 0.0006). After adjusting for age and sex, multivariate logistic regression analysis demonstrated a significant association of overlap syndrome with microalbuminuria compared with OSA (odds ratio, 2.61; 95% confidence interval, 1.02-6.38; P = 0.047), but after adjusting for other confounding factors, the difference in the association did not reach significance (odds ratio, 2.54; 95% confidence interval, 0.93-6.72; P = 0.070). Of 63 patients reevaluated after 3 months of continuous positive airway pressure therapy, the logarithm of the albumin-creatinine ratio in 36 patients with good compliance significantly decreased, but there was no difference in patients with poor compliance.Conclusions: OSA-COPD overlap syndrome was more prevalent than OSA alone in patients with microalbuminuria, but the difference might be mediated by conventional risk factors rather than the addition of COPD itself. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
23. Association of Sleep-disordered Breathing and Blood Pressure with Albuminuria: The Nagahama Study.
- Author
-
Murase K, Matsumoto T, Tabara Y, Ohler A, Gozal D, Minami T, Kanai O, Takeyama H, Takahashi N, Hamada S, Tanizawa K, Wakamura T, Komenami N, Setoh K, Kawaguchi T, Tsutsumi T, Morita S, Takahashi Y, Nakayama T, Yanagita M, Hirai T, Matsuda F, and Chin K
- Subjects
- Blood Pressure physiology, Humans, Oximetry, Sleep, Albuminuria epidemiology, Sleep Apnea Syndromes epidemiology
- Abstract
Rationale: Although sleep-disordered breathing (SDB) may increase urinary albumin excretion (UAE) by raising nocturnal blood pressure (BP) in addition to diurnal BP, the correlation has not been investigated in a general population. Objectives: To evaluate the relationships among UAE, SDB, and BP during sleep in a large population cohort. Methods: Among 9,850 community residents, UAE was assessed by the urinary albumin-to-creatinine ratio (UACR) in spot urine. Sleep duration and SDB were evaluated by a wearable actigraph and pulse oximeter, respectively. We calculated the actigraphy-modified 3% oxygen desaturation index (Acti-3%ODI) by correcting the time measured by pulse oximetry according to sleep duration obtained by actigraphy. Furthermore, participants were instructed to measure morning and sleep BP at home by a timer-equipped oscillometric device. Results: Measurements of sleep parameters, UAE, and office BP were obtained in 6,568 participants. The multivariate analysis that included confounders showed a significant association of Acti-3%ODI with UACR (β = 0.06, P < 0.001). Furthermore, a positive interaction between office systolic BP (SBP) and Acti-3%ODI for UACR was found (β = 0.06, P < 0.001). Among the 6,568 persons enrolled in the analysis, 5,313 completed measurements of BP at home. In this cohort, the association of Acti-3%ODI with UACR remained significant (β = 0.06, P < 0.001) even after morning and sleep SBP were included in the analysis. Furthermore, a mediation analysis revealed that 28.3% (95% confidence interval, 14.9-41.7%; P < 0.001) of the association of Acti-3%ODI with UACR was explained by the mediation of morning and sleep SBP metrics. Conclusions: SDB and office SBP were independently and synergistically associated with UAE, which is considered a risk factor for chronic kidney disease and cardiovascular events. SDB may raise UAE not only by increasing BP but also by involving other pathologic pathways.
- Published
- 2022
- Full Text
- View/download PDF
24. Differences between subjective and objective sleep duration according to actual sleep duration and sleep-disordered breathing: the Nagahama Study.
- Author
-
Takahashi N, Matsumoto T, Nakatsuka Y, Murase K, Tabara Y, Takeyama H, Minami T, Hamada S, Kanai O, Tanizawa K, Nakamoto I, Kawaguchi T, Setoh K, Tsutsumi T, Takahashi Y, Handa T, Wakamura T, Komenami N, Morita S, Hirai T, Matsuda F, Nakayama T, and Chin K
- Subjects
- Actigraphy, Cross-Sectional Studies, Female, Humans, Male, Oxygen, Sleep, Sleep Apnea Syndromes complications, Sleep Apnea Syndromes epidemiology
- Abstract
Study Objectives: Since subjective sleep duration (SSD) is considered to be longer than objective sleep duration (OSD), results of SSD minus OSD (SSD-OSD) might always be thought to be positive. Some recent reports showed different results, but exact results have not been obtained. The difference between SSD and OSD may change according to OSD. We investigated this difference and its association with sleep-disordered breathing (SDB) or nonrestorative sleep., Methods: This cross-sectional study evaluated 6,908 community residents in Nagahama, Japan. SSD was determined by self-administered questionnaire. OSD was measured by wrist actigraphy and sleep diary. SDB was assessed according to the 3% oxygen desaturation index adjusted for OSD., Results: Worthy of notice was that SSD was shorter than OSD for those with SSD longer than 6.98 hours in all participants, 7.36 hours in males, and 6.80 hours in females. However, SSD was longer than OSD (mean ± SD: 6.49 ± 1.07 vs 6.01 ± 0.96; P < .001) overall, as SSD is considered to be longer than OSD. In patients with SDB, the difference between SSD-OSD was greater when OSD was s horter. The difference also depended on SDB severity. The degree of positivity between OSD and SSD was a significant factor in nonrestorative sleep (odds ratio: 2.691; P < .001)., Conclusions: When OSD was slightly less than 7 (6.98) hours, participants reported or perceived SSD > OSD. When OSD was > 6.98 hours, participants reported or perceived SSD < OSD. Patients with SDB reported longer SSD than OSD according to severity of SDB. Evaluating SSD, OSD, and their differences may be useful for managing sleep disturbances, including nonrestorative sleep., Citation: Takahashi N, Matsumoto T, Nakatsuka Y, et al. Differences between subjective and objective sleep duration according to actual sleep duration and sleep-disordered breathing: the Nagahama Study. J Clin Sleep Med . 2022;18(3):851-859., (© 2022 American Academy of Sleep Medicine.)
- Published
- 2022
- Full Text
- View/download PDF
25. Markers of cardiovascular disease risk in sleep-disordered breathing with or without comorbidities: the Nagahama study.
- Author
-
Nakatsuka Y, Murase K, Matsumoto T, Tabara Y, Nakamoto I, Minami T, Takahashi N, Takeyama H, Kanai O, Hamada S, Tanizawa K, Handa T, Wakamura T, Komenami N, Morita S, Nakayama T, Hirai T, Matsuda F, and Chin K
- Subjects
- Ankle Brachial Index, Biomarkers, Carotid Intima-Media Thickness, Cross-Sectional Studies, Humans, Pulse Wave Analysis, Risk Factors, Cardiovascular Diseases epidemiology, Sleep Apnea Syndromes complications, Sleep Apnea Syndromes epidemiology
- Abstract
Study Objectives: Whether the association between sleep-disordered breathing (SDB) and cardiovascular disease is independent of comorbid risk factors for cardiovascular disease is controversial. The objective of this study was to elucidate whether the association between SDB severity and the surrogate markers of cardiovascular disease events differs in relation to the number of comorbidities., Methods: This cross-sectional study included 7,731 participants. Severity of SDB was determined by the oxygen desaturation index adjusted by actigraph-measured objective sleep time. Participants were stratified according to SDB severity and the number of comorbidities (hypertension, diabetes, dyslipidemia, and obesity), and the associations between the maximum value of intima-media thickness of the common carotid artery (CCA-IMT-max), brachial-ankle pulse wave velocity, and cardio-ankle vascular index were evaluated., Results: Among participants with no risk factors, CCA-IMT-max increased according to SDB severity (n = 1022, P < .0001). Even after matching the background, the median CCA-IMT-max value was 14% higher in moderate-severe SDB patients than those without SDB (n = 45 in each group, P = .020). The difference was not significant for brachial-ankle pulse wave velocity and cardio-ankle vascular index. On the other hand, a significant difference in CCA-IMT-max was not found in those with multiple comorbidities. Consistently, multiple regression analysis revealed an independent association between CCA-IMT-max and moderate-severe SDB for all study participants (β: 0.0222, 95% confidence interval: 0.0039-0.0405, P = .017), but the association was not significant for stratified participants with multiple comorbidities., Conclusions: SDB severity is associated with the CCA-IMT-max level, but the independent association becomes weaker for those with multiple comorbidities., Citation: Nakatsuka Y, Murase K, Matsumoto T, et al. Markers of cardiovascular disease risk in sleep-disordered breathing with or without comorbidities: the Nagahama Study. J Clin Sleep Med . 2021;17(12):2467-2475., (© 2021 American Academy of Sleep Medicine.)
- Published
- 2021
- Full Text
- View/download PDF
26. Impact of sleep-disordered breathing on glucose metabolism among individuals with a family history of diabetes: the Nagahama study.
- Author
-
Minami T, Matsumoto T, Tabara Y, Gozal D, Smith D, Murase K, Tanizawa K, Takahashi N, Nakatsuka Y, Hamada S, Handa T, Takeyama H, Oga T, Nakamoto I, Wakamura T, Komenami N, Setoh K, Tsutsumi T, Kawaguchi T, Kamatani Y, Takahashi Y, Morita S, Nakayama T, Hirai T, Matsuda F, and Chin K
- Subjects
- Female, Glucose, Humans, Male, Middle Aged, Oximetry, Prevalence, Risk Factors, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 epidemiology, Sleep Apnea Syndromes complications, Sleep Apnea Syndromes epidemiology
- Abstract
Study Objectives: It is well known that a family history of diabetes (FHD) is a definitive risk factor for type 2 diabetes. It has not been known whether sleep-disordered breathing (SDB) increases the prevalence of diabetes in those with an FHD., Methods: We assessed SDB severity in 7,477 study participants by oximetry corrected by objective sleep duration determined by wrist actigraphy. Glycated hemoglobin ≥6.5% and/or current medication for diabetes indicated the presence of diabetes. In addition to the overall prevalence, the prevalence of recent-onset diabetes during the nearly 5 years before the SDB measurements were made was investigated., Results: Of the 7,477 participants (mean age: 57.9; range: 34.2-80.7; SD: 12.1 years; 67.7% females), 1,569 had an FHD. The prevalence of diabetes in FHD participants with moderate-to-severe SDB (MS-SDB) was higher than in those without SDB (MS-SDB vs without SDB: all, 29.3% vs 3.3% [P < .001]; females, 32.6% vs 1.9% [P < .001]; males, 26.2% vs 11.7% [P = .037]). However, multivariate analysis showed that MS-SDB was significantly associated with a higher prevalence of diabetes only in FHD-positive females (odds ratio [95% confidence interval]: females, 7.43 [3.16-17.45]; males, 0.92 [0.37-2.31]). Among the FHD-positive participants, the prevalence of recent-onset diabetes was higher in those with MS-SDB than those without SDB, but only in females (MS-SDB vs without SDB: 21.4% vs 1.1%; P < 0.001)., Conclusions: MS-SDB was associated with diabetes risk in females with an FHD, and future studies are needed on whether treatment of SDB in females with an FHD would prevent the onset of diabetes., (© 2021 American Academy of Sleep Medicine.)
- Published
- 2021
- Full Text
- View/download PDF
27. Sleep disordered breathing and metabolic comorbidities across sex and menopausal status in East Asians: the Nagahama Study.
- Author
-
Matsumoto T, Murase K, Tabara Y, Minami T, Kanai O, Takeyama H, Takahashi N, Hamada S, Tanizawa K, Wakamura T, Komenami N, Setoh K, Kawaguchi T, Tsutsumi T, Morita S, Takahashi Y, Nakayama T, Hirai T, Matsuda F, and Chin K
- Subjects
- Asian People, Cross-Sectional Studies, Female, Humans, Male, Oximetry, Premenopause, Prevalence, Sleep Apnea Syndromes epidemiology
- Abstract
It is well known that the prevalence of sleep disordered breathing (SDB) is increased in patients with obesity or metabolic comorbidities. However, the way in which the prevalence of SDB increases in relation to comorbidities according to the severity of obesity remains unclear.This cross-sectional study evaluated 7713 community participants using nocturnal oximetry ≥2 nights. SDB was assessed by the 3% oxygen desaturation index corrected for sleep duration obtained by wrist actigraphy (acti-ODI3%). SDB severity was defined by acti-ODI3%. Obesity was defined as body mass index ≥25 kg·m
-2 The prevalence of SDB was 41.0% (95% CI 39.9-42.1%), 46.9% (45.8-48.0%), 10.1% (9.5-10.8%) and 2.0% (1.7-2.3%) in normal, mild, moderate and severe SDB, respectively, with notable sex differences evident (males>post-menopausal females>premenopausal females). Comorbidities such as hypertension, diabetes and metabolic syndrome were independently associated with the prevalence of moderate-to-severe SDB, and coincidence of any one of these with obesity was associated with a higher probability of moderate-to-severe SDB (hypertension OR 8.2, 95% CI 6.6-10.2; diabetes OR 7.8, 95% CI 5.6-10.9; metabolic syndrome OR 6.7, 95% CI 5.2-8.6). Dyslipidaemia in addition to obesity was not additively associated with the prevalence of moderate-to-severe SDB. The number of antihypertensive drugs was associated with SDB (p for trend <0.001). Proportion of a high cumulative percentage of sleep time with oxygen saturation measured by pulse oximetry <90% increased, even among moderate-to-severe SDB with increases in obesity.Metabolic comorbidities contribute to SDB regardless of the degree of obesity. We should recognise the extremely high prevalence of moderate-to-severe SDB in patients with obesity and metabolic comorbidities., Competing Interests: Conflict of interest: T. Matsumoto has nothing to disclose. K. Murase reports grants from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Keiji, ResMed and Japan Society for the Promotion of Science, outside the submitted work. Conflict of interest: Y. Tabara reports grants from Japan Agency for Medical Research and Development (AMED) and The Ministry of Education, Culture, Sports, Science and Technology in Japan, during the conduct of the study. Conflict of interest: T. Minami reports personal fees from Teijin Zaitakuiryou, outside the submitted work. Conflict of interest: O. Kanai has nothing to disclose. Conflict of interest: H. Takeyama reports grants from Philips-Respironics, ResMed, Fukuda Denshi, Fukuda Lifetec Keiji and Teijin Pharma, outside the submitted work. Conflict of interest: N. Takahashi reports grants from Philips-Respironics, ResMed, Fukuda Denshi and Fukuda Lifetec Keiji, outside the submitted work. Conflict of interest: S. Hamada reports grants from Teijin Pharma, outside the submitted work. Conflict of interest: K. Tanizawa has nothing to disclose. Conflict of interest: T. Wakamura has nothing to disclose. Conflict of interest: N. Komenami has nothing to disclose. Conflict of interest: K. Setoh has nothing to disclose. Conflict of interest: T. Kawaguchi has nothing to disclose. Conflict of interest: T. Tsutsumi has nothing to disclose. Conflict of interest: S. Morita has nothing to disclose. Conflict of interest: Y. Takahashi has nothing to disclose. Conflict of interest: T. Nakayama has nothing to disclose. Conflict of interest: T. Hirai has nothing to disclose. Conflict of interest: F. Matsuda reports grants from Kyoto University, the Ministry of Education, Culture, Sports, Science and Technology in Japan, Japan Agency for Medical Research and Development (AMED) and The Takeda Medical Research Foundation, during the conduct of the study. Conflict of interest: K. Chin reports grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, grants from the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, the Ministry of Health, Labour and Welfare, Japan, grants from the Research Foundation for Healthy Aging, grants from Health, Labour and Welfare Sciences Research Grants, Research on Region Medical, grants from the Center of Innovation Program, and the Global University Project from Japan Science and Technology Agency, Japan Agency for Medical Research and Development, during the conduct of the study; grants and personal fees from Philips-Respironics, Teijin Pharma, Fukuda Denshi, Fukuda Lifetec Keiji, GlaxoSmithKline and Resmed, grants from KYORIN Pharmaceutical Co., Ltd and Nippon Boehringer Ingelheim Co., Ltd, personal fees from MSD, Astellas Pharma and Eisai Co., Ltd, outside the submitted work., (Copyright ©ERS 2020.)- Published
- 2020
- Full Text
- View/download PDF
28. A Randomized Controlled Trial of Telemedicine for Long-Term Sleep Apnea Continuous Positive Airway Pressure Management.
- Author
-
Murase K, Tanizawa K, Minami T, Matsumoto T, Tachikawa R, Takahashi N, Tsuda T, Toyama Y, Ohi M, Akahoshi T, Tomita Y, Narui K, Nakamura H, Ohdaira T, Yoshimine H, Tsuboi T, Yamashiro Y, Ando S, Kasai T, Kita H, Tatsumi K, Burioka N, Tomii K, Kondoh Y, Takeyama H, Handa T, Hamada S, Oga T, Nakayama T, Sakamaki T, Morita S, Kuroda T, Hirai T, and Chin K
- Subjects
- Aged, Female, Humans, Japan, Male, Middle Aged, Patient Education as Topic methods, Prospective Studies, Treatment Outcome, Continuous Positive Airway Pressure methods, Patient Compliance statistics & numerical data, Sleep Apnea, Obstructive therapy, Telemedicine methods
- Abstract
Rationale: The effects of telemedicine on adherence in patients with obstructive sleep apnea with long-term continuous positive airway pressure (CPAP) use have never been investigated. Objectives: To examine effects of a telemedicine intervention on adherence in long-term CPAP users. Methods: In a prospective, randomized, multicenter noninferiority trial conducted in 17 sleep centers across Japan, patients who had used CPAP for >3 months and were receiving face-to-face follow-up by physicians every 1 or 2 months were randomized by a coordinating center in a blind manner to the following three groups: 1 ) follow-up every 3 months accompanied by a monthly telemedicine intervention (telemedicine group: TM-group), 2 ) follow-up every 3 months (3-month group: 3M-group), or 3 ) monthly follow-up (1-month group: 1M-group). Each group was followed up for 6 months. The change in percentage of days with ≥4 h/night of CPAP use from baseline to the end of the study period was evaluated. A decline of ≥5% from baseline was considered deterioration of adherence. Noninferiority of TM- and 3M-groups compared with the 1M-group according to the number of patients with deterioration of adherence was evaluated with the Farrington and Manning test (noninferiority margin 15%). Results: A total of 483 patients were analyzed (median duration of CPAP use, 29 [interquartile range, 12-71] mo), and deterioration of adherence was found in 41 of 161 (25.5%), 55 of 166 (33.1%), and 35 of 156 (22.4%) patients in the TM-, 3M-, and 1M-groups, respectively. The noninferiority of the TM-group compared with the 1M-group was verified (difference in percentage of patients with adherence deterioration, 3.0%; 95% confidence interval [CI], -4.8% to 10.9%; P < 0.01). Conversely, the 3M-group did not show noninferiority to the 1M-group (percentage difference, 10.7%; 95% CI, 2.6% to 18.8%; P = 0.19). In the stratified analysis, adherence in TM- and 1M-group patients with poor adherence at baseline improved (TM: 45.8% ± 18.2% to 57.3% ± 24.4%; P < 0.01; 1M: 43.1% ± 18.5% to 53.6% ± 24.3%; P < 0.01), whereas that of the 3M-group did not (39.3% ± 20.8% to 39.8% ± 24.8%; P = 0.84). Conclusions: Intensive telemedicine support could help to optimize CPAP adherence even after long-term CPAP use.Clinical trial registered with www.umin.ac.jp/ctr/index.htm (trial number: UMIN000023118).
- Published
- 2020
- Full Text
- View/download PDF
29. Impact of sleep characteristics and obesity on diabetes and hypertension across genders and menopausal status: the Nagahama study.
- Author
-
Matsumoto T, Murase K, Tabara Y, Gozal D, Smith D, Minami T, Tachikawa R, Tanizawa K, Oga T, Nagashima S, Wakamura T, Komenami N, Setoh K, Kawaguchi T, Tsutsumi T, Takahashi Y, Nakayama T, Hirai T, Matsuda F, and Chin K
- Subjects
- Actigraphy, Adult, Aged, Aged, 80 and over, Body Mass Index, Cross-Sectional Studies, Female, Humans, Japan epidemiology, Male, Middle Aged, Odds Ratio, Oximetry, Oxygen, Prevalence, Risk Factors, Sex Factors, Sleep, Time Factors, Diabetes Mellitus epidemiology, Hypertension epidemiology, Obesity epidemiology, Postmenopause, Premenopause, Sleep Apnea Syndromes epidemiology
- Abstract
Study Objectives: The individual prevalence of sleep-disordered breathing (SDB), short sleep duration, and obesity is high and increasing. The study aimed to investigate potential associations between SDB, objective sleep duration, obesity, diabetes and hypertension across genders, and the effect of pre- or post-menopausal status., Methods: A cross-sectional study evaluated 7051 community participants with wrist actigraphy for a week, and nocturnal oximetry ≥ 2 nights. SDB was assessed by 3 per cent oxygen desaturation index (ODI) corrected for sleep duration obtained from wrist actigraphy. Moderate-to-severe SDB was defined as ODI3% levels ≥ 15 per hour., Results: Both logODI3% and body mass index showed independent negative associations with sleep duration (β = -0.16, p < 0.001 and β = -0.07, p < 0.001, respectively). Moderate-to-severe SDB (men/premenopausal women/postmenopausal women; 23.7/1.5/9.5%, respectively) was associated with a higher risk of diabetes in premenopausal women (OR 28.1; 95%CI 6.35-124.6; p < 0.001) and postmenopausal women (OR 3.25; 95%CI 1.94-5.46; p < 0.001), but not in men (OR 1.47; 95%CI 0.90-2.40; p = 0.119). Moderate-to-severe SDB was associated with a higher risk of hypertension in men (OR 3.11; 95%CI 2.23-4.33; p < 0.001), premenopausal women (OR 3.88; 95%CI 1.42-10.6; p = 0.008), and postmenopausal women (OR 1.96; 95%CI 1.46-2.63; p < 0.001). Short sleep duration was not associated with diabetes or hypertension. The associations of obesity with diabetes or hypertension were indirectly mediated by SDB (24.0% and 21.5%, respectively), with possible sex differences emerging (men/women; 15.3/27.8% and 27.0/16.9%, respectively)., Conclusions: Notwithstanding the cross-sectional design, SDB and obesity, but not short sleep duration, were independently associated with diabetes and hypertension, with gender and menopausal status-related differences in risk emerging.
- Published
- 2018
- Full Text
- View/download PDF
30. Associations of obstructive sleep apnea with truncal skeletal muscle mass and density.
- Author
-
Matsumoto T, Tanizawa K, Tachikawa R, Murase K, Minami T, Inouchi M, Handa T, Oga T, Hirai T, and Chin K
- Subjects
- Adiposity physiology, Body Mass Index, Female, Humans, Male, Middle Aged, Obesity physiopathology, Polysomnography methods, Retrospective Studies, Risk Factors, Severity of Illness Index, Muscle, Skeletal physiopathology, Sleep Apnea, Obstructive physiopathology
- Abstract
Sarcopenia has been associated with several conditions relevant to obstructive sleep apnea (OSA), such as aging and obesity, but a direct relationship between OSA and skeletal muscle alterations has not been identified. This study investigated associations between computed tomography (CT)-measured skeletal muscle indices and OSA severity. Analyzed were 334 patients who underwent polysomnography to diagnose OSA. Lumbar skeletal muscles were assessed with CT for the skeletal muscle mass index (SMI, cross-sectional area, normalized for height squared) and skeletal muscle density (SMD, fat infiltration). The apnea-hypopnea index (AHI) correlated positively with the SMI and negatively with SMD in both men and women. The AHI was weakly associated with SMI only in men (β = 0.11, P = 0.017) after adjustment for the body mass index (BMI) (BMI: β = 0.61, P < 0.001 in men, β = 0.65, P < 0.001 in women). The association of AHI and SMD was not significant after adjustment for BMI (BMI: β = -0.42, P < 0.001 in men, β = -0.64, P < 0.001 in women). Severity of OSA correlated with increases in skeletal muscle mass rather than muscle depletion and skeletal muscle adiposity. These associations were limited compared with the stronger associations between obesity and skeletal muscles.
- Published
- 2018
- Full Text
- View/download PDF
31. Changes in Habitual Sleep Duration after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.
- Author
-
Tachikawa R, Minami T, Matsumoto T, Murase K, Tanizawa K, Inouchi M, Oga T, and Chin K
- Subjects
- Actigraphy, Aged, Anxiety psychology, Depression psychology, Female, Humans, Japan, Linear Models, Male, Middle Aged, Multivariate Analysis, Polysomnography, Prospective Studies, Psychiatric Status Rating Scales, Quality of Life, Severity of Illness Index, Surveys and Questionnaires, Time Factors, Continuous Positive Airway Pressure, Sleep physiology, Sleep Apnea, Obstructive psychology, Sleep Apnea, Obstructive therapy, Sleep Stages physiology
- Abstract
Rationale: Obstructive sleep apnea (OSA) can affect not only sleep quality but also sleep duration. Determining the therapeutic effects of continuous positive airway pressure (CPAP) on habitual sleep profiles may shed light on the impact of OSA on sleep duration., Objectives: To determine whether and how CPAP affects habitual sleep duration in patients with OSA., Methods: Assessments of sleep duration and sleep quality were performed on 57 newly diagnosed study subjects with OSA (46 men; median age, 63 yr; apnea-hypopnea index, >20 h
-1 ) at baseline and 3 months after initiation of CPAP therapy. Measurements included in-laboratory sleep tests (polysomnography), assessments of habitual sleep (actigraphy with sleep diary for 7 d), and questionnaires on subjective symptoms (Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, and Hospital Anxiety and Depression Scale)., Results: Actigraphic night sleep time did not change after CPAP (from 354.0 ± 64.5 min to 353.0 ± 57.0 min; P = 0.87) in the entire group, despite improvements in sleep efficiency and sleep fragmentation. Changes in habitual night sleep duration varied among the participants; habitual night sleep duration increased by 33 minutes (interquartile range, 14-45 min) in 28 participants (sleep time restorers) and decreased by 23 minutes (interquartile range, -48 to -11 min) in 29 participants (sleep time nonrestorers). Subgroup analyses revealed that sleep time restorers were characterized at baseline as having shorter and more fragmented sleep with frequent daytime napping. Nonrestorers were characterized by frequent use of hypnotic drugs and comorbid insomnia, despite longer habitual sleep duration. Actigraphic sleep fragmentation, sleep efficiency, daytime sleepiness, and the frequency of daytime napping were improved after CPAP only in the sleep time restorers, whereas subjective sleep quality was improved in the nonrestorers. Multivariate linear regression showed that shorter baseline night sleep time, baseline daytime napping, and percentage of sleep time under CPAP were positive predictors of the restoration of actigraphic night sleep time, whereas hypnotic use was a negative predictor., Conclusions: Short-term CPAP did not affect habitual night sleep duration in the group as a whole but induced intraindividual changes in relation to phenotypic features of OSA. Clinical trial registered with www.umin.ac.jp (UMIN000012639).- Published
- 2017
- Full Text
- View/download PDF
32. Relationship between obstructive sleep apnea and endogenous carbon monoxide.
- Author
-
Azuma M, Murase K, Tachikawa R, Hamada S, Matsumoto T, Minami T, Inouchi M, Tanizawa K, Handa T, Oga T, Mishima M, and Chin K
- Subjects
- Biomarkers blood, Biomarkers metabolism, Continuous Positive Airway Pressure methods, Exhalation physiology, Female, Heme Oxygenase-1 metabolism, Humans, Hypoxia blood, Hypoxia metabolism, Hypoxia physiopathology, Male, Middle Aged, Oxidative Stress physiology, Oxygen metabolism, Prospective Studies, Pulmonary Gas Exchange physiology, Sleep physiology, Sleep Apnea, Obstructive metabolism, Carbon Monoxide blood, Carbon Monoxide metabolism, Sleep Apnea, Obstructive blood, Sleep Apnea, Obstructive physiopathology
- Abstract
Endogenous carbon monoxide (CO) levels are recognized as a surrogate marker for activity of heme oxygenase-1, which is induced by various factors, including hypoxia and oxidative stress. Few reports have evaluated endogenous CO in patients with obstructive sleep apnea (OSA). Whether OSA more greatly affects exhaled or blood CO is not known. Sixty-nine patients with suspected OSA were prospectively included in this study. Exhaled and blood CO were evaluated at night and morning. Blood and exhaled CO levels were well correlated both at night and morning (r = 0.52, P < 0.0001 and r = 0.61, P < 0.0001, respectively). Although exhaled CO levels both at night and morning significantly correlated with total sleep time with arterial oxygen saturation < 90% (ρ = 0.41, P = 0.0005 and ρ = 0.27, P = 0.024, respectively), blood CO levels did not correlate with any sleep parameter. Seventeen patients with an apnea and hypopnea index (AHI) < 15 (control group) were compared with 52 patients with AHI ≥ 15 (OSA group). Exhaled CO levels at night in the OSA group were significantly higher than in the control group (3.64 ± 1.2 vs. 2.99 ± 0.70 ppm, P < 0.05). Exhaled CO levels at night decreased after 3 mo of continuous positive airway pressure (CPAP) therapy in OSA patients (n = 36; P = 0.016) to become nearly the same level as in the control group (P = 0.21). Blood CO levels did not significantly change after CPAP therapy. Exhaled CO was positively related to hypoxia during sleep in OSA patients, but blood CO was not. Exhaled CO might better correlate with oxidative stress associated with OSA than blood CO., New & Noteworthy: Endogenous carbon monoxide (CO) levels are recognized to be a surrogate marker of oxidative stress. No study has evaluated both exhaled and blood CO at the same time in obstructive sleep apnea (OSA) patients. Here we provide evidence that exhaled CO levels positively correlated with hypoxia during sleep in OSA patients, but blood CO levels did not, and that continuous positive airway pressure therapy significantly decreased exhaled CO levels in the OSA group, but did not significantly affect blood CO., (Copyright © 2017 the American Physiological Society.)
- Published
- 2017
- Full Text
- View/download PDF
33. Changes in Energy Metabolism after Continuous Positive Airway Pressure for Obstructive Sleep Apnea.
- Author
-
Tachikawa R, Ikeda K, Minami T, Matsumoto T, Hamada S, Murase K, Tanizawa K, Inouchi M, Oga T, Akamizu T, Mishima M, and Chin K
- Subjects
- Basal Metabolism, Energy Intake, Exercise, Female, Ghrelin blood, Humans, Hydrocortisone blood, Insulin-Like Growth Factor I analysis, Leptin blood, Male, Middle Aged, Norepinephrine blood, Polysomnography, Sleep Apnea, Obstructive metabolism, Continuous Positive Airway Pressure, Energy Metabolism, Sleep Apnea, Obstructive therapy
- Abstract
Rationale: Disrupted energy homeostasis in obstructive sleep apnea (OSA) may lead to weight gain. Paradoxically, treating OSA with continuous positive airway pressure (CPAP) may also promote weight gain, although the underlying mechanism remains unclear., Objectives: To explore the underlying mechanism by which patients with OSA gain weight after CPAP., Methods: A comprehensive assessment of energy metabolism was performed in 63 newly diagnosed OSA study participants (51 men; 60.8 ± 10.1 yr; apnea-hypopnea index >20 h(-1)) at baseline, CPAP initiation, and at a 3-month follow-up. Measurements included polysomnography, body weight, body composition, basal metabolic rate (BMR), hormones (norepinephrine, cortisol, leptin, ghrelin, insulin-like growth factor-1), dietary intake, eating behavior, and physical activity., Measurements and Main Results: BMR significantly decreased after CPAP (1,584 kcal/d at baseline, 1,561 kcal/d at CPAP initiation, and 1,508 kcal/d at follow-up; P < 0.001), whereas physical activity and total caloric intake did not significantly change. In multivariate regression, baseline apnea-hypopnea index, Δurine norepinephrine, and CPAP adherence were significant predictors of ΔBMR. The weight gainers had higher leptin levels, lower ghrelin levels, and higher eating behavior scores than the non-weight gainers, indicating a positive energy balance and disordered eating behavior among the weight gainers. Among the parameters related to energy metabolism, increased caloric intake was a particularly significant predictor of weight gain., Conclusions: Although a reduction in BMR after CPAP predisposes to a positive energy balance, dietary intake and eating behavior had greater impacts on weight change. These findings highlight the importance of lifestyle modifications combined with CPAP. Clinical trial registered with http://www.umin.ac.jp/english/ (UMIN000012639).
- Published
- 2016
- Full Text
- View/download PDF
34. Plasma Incretin Levels and Dipeptidyl Peptidase-4 Activity in Patients with Obstructive Sleep Apnea.
- Author
-
Matsumoto T, Harada N, Azuma M, Chihara Y, Murase K, Tachikawa R, Minami T, Hamada S, Tanizawa K, Inouchi M, Oga T, Mishima M, and Chin K
- Subjects
- Adult, Aged, Fasting, Female, Gastric Inhibitory Polypeptide blood, Glucagon-Like Peptide 1 blood, Humans, Japan, Male, Middle Aged, Regression Analysis, Dipeptidyl Peptidase 4 blood, Glucose Intolerance blood, Incretins blood, Sleep Apnea, Obstructive blood
- Abstract
Rationale: Incretin hormones, namely glucagon-like peptide-1 (GLP-1) and gastric inhibitory polypeptide/glucose-dependent insulinotropic polypeptide (GIP), and dipeptidyl peptidase-4 (DPP-4) activity are important factors in glucose metabolism and have not been investigated in patients with obstructive sleep apnea (OSA)., Objectives: The objective of this study was to investigate the association between OSA and incretin and DPP-4 activity., Methods: This study included 96 consecutive patients without diabetes who were suspected of having OSA. We investigated the fasting and post-prandial incremental area under the curve (IAUC) of GLP-1, GIP serum levels, and serum DPP-4 activity levels, as well as their association with OSA. Changes in clinical variables were evaluated in the 43 patients who continued continuous positive airway pressure therapy for 3 months., Measurements and Main Results: Apnea-hypopnea index was an independent determining factor for fasting GLP-1 (β = 0.31; P = 0.0019) and IAUC GIP (β = -0.21; P = 0.037) after adjusting for known confounding factors. In those with very severe OSA (apnea-hypopnea index ≥50), the IAUCs for GLP-1 and GIP were significantly decreased, while fasting GLP-1 and fasting GIP were significantly increased. DPP-4 activity had no relation to OSA parameters or severity, while body mass index was significantly higher in those with severe OSA. Although significant changes in incretin secretion were not seen for 3 months after onset of continuous positive airway pressure therapy, the fasting GLP-1 level in the treated patients with severe OSA decreased to the same level as in untreated patients with normal to moderately severe OSA., Conclusions: OSA is associated with elevated serum levels of the incretin hormones GLP-1 (fasting) and GIP (post-prandial) in patients without diabetes. A significant association between body mass index and DPP-4, which is said to exist in healthy persons, was not found in the patients with OSA. Fasting GLP-1 in patients without diabetes with OSA may influence fasting glucose levels.
- Published
- 2016
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.